Daniel Rush

SVP, Strategy & Transformation at Waters

Dr. Daniel Rush was appointed Senior Vice President, Strategy and Transformation of Waters Corporation in 2021. He collaborates with the Executive Committee to develop and operationalize worldwide enterprise strategy.

Prior to joining Waters, Dan served as Vice President, Worldwide Commercialization Strategy & Innovation at Bristol Myers Squibb (BMS), where he led its digital customer model transformation and was responsible for implementing a novel innovation system across Commercial, Medical and Market Access. Prior to BMS, he spent eight years at Novartis in a variety of sales, marketing, and strategy leadership roles, including Head of Global Pharma Strategy, U.S. Launch Lead for Afinitor® and U.S. Marketing Director for Zometa®. Dan began his career as a chemist in Pharmaceutical R&D at Merck, following a post-doc in materials science at the University of California, Irvine and Sandia National Laboratories.

He earned a B.A. in chemistry and history from Bowdoin College and a Ph.D. in physical organic chemistry from Yale University.


Previous companies

Novartis logo
Merck logo
Bristol-Myers Squibb logo


  • SVP, Strategy & Transformation

    Current role

View in org chart